Research Article

Prevalence and Possible Risk Factors of Low Bone Mineral Density in Untreated Female Patients with Systemic Lupus Erythematosus

Table 3

Characteristics of SLE patients with normal and low BMD at lumbar spine and total hip.

VariableNormal BMDLow BMD

Demographic variables
 Age#31.6 ± 8.933.9 ± 16.10.869
 BMI#20.7 ± 3.520.3 ± 2.80.730
Clinical variables
 Disease duration#24.1 ± 34.720.1 ± 34.50.895
 Serum creatinine#54.6 ± 26.755.2 ± 20.30.651
 Serum albumin#31.7 ± 5.832.3 ± 8.60.216
 24-hour urine protein#0.56 ± 0.750.62 ± 1.020.586
 Serum TC#3.3 ± 0.94.2 ± 1.80.007
 Serum triglyceride#2.0 ± 1.12.0 ± 1.70.332
 Serum LDL-c#1.9 ± 0.62.4 ± 1.20.055
 ESR#56.1 ± 34.754.9 ± 33.00.948
 CRP#10.8 ± 12.910.8 ± 12.70.963
 Complement 3#0.57 ± 0.320.59 ± 0.330.892
 Complement 4#0.10 ± 0.090.10 ± 0.090.909
 SLEDAI#11.7 ± 6.010.8 ± 5.20.579
Bone metabolism variables
 Serum 25-[OH]D#12.2 ± 7.811.8 ± 6.70.995
 Serum calcium2.0 ± 0.22.0 ± 0.20.978
 Serum phosphate1.2 ± 0.31.0 ± 0.30.715
 PTH#34.8 ± 23.738.1 ± 21.30.342
 OC#10.1 ± 5.511.2 ± 7.90.880
 CTX#500.8 ± 357.8633.7 ± 498.00.373

The Student -test; Mann-Whitney test.
BMD = bone mineral density; BMI = body mass index; TC = total cholesterol; LDL-c = low density lipoprotein cholesterol; ESR = erythrocyte sedimentation rate; CRP = C-reactive protein; SLEDAI = Systemic Lupus Erythematosus Disease Activity Index; 25-[OH]D = 25-hydroxyvitamin D; PTH = parathyroid hormone; OC = osteocalcin; CTX = C-terminal cross-linking telopeptide of type I collagen.